Opioid dependence is a chronic disease of the brain, characterised by three drivers: drug liking, withdrawal and craving.1–3 Historically, opioid dependence has been linked to illicit heroin use, but over the last 15 years in Australia there has been a considerable increase in the abuse of pharmaceutical opioids, usually prescribed or dispensed for chronic pain.4 It has been estimated that approximately 1 in 20 people prescribed an opioid painkiller in Australia may become dependent at some point in their lives.5,6

Turn To Help is a site dedicated to the treatment of opioid dependence. In this website, you will find information that will help you identify opioid-dependent patients in your practice, as well as guidance on how to manage their condition in the long term.

Newly released NSW Guidelines for the treatment of opioid dependence.
View the July 2018 Guidelines
Suboxone Film Product Information (Updated 2018)
Dr Hance Clarke presents on the importance of multidisciplinary management of opioid-dependent patients.
How to treat codeine dependency with Suboxone.

The need
Identify the three drivers of opioid dependence, and help determine whether your patients are at risk.
Learn more
Treating dependence
Find the right treatment option for your patients with opioid dependence.
Learn more
Suboxone® Film*7 (buprenorphine hydrochloride/naloxone hydrochloride dihydrate)Suboxone® Film
As of 2018, the Suboxone® Film Product Information was updated to include a number of important changes.*Suboxone® Film is indicated for the treatment of opioid dependence within a framework of medical, social and psychological treatment.7
Learn more
Pharmacy requirements
Information for pharmacists on becoming dosing points for Suboxone® Film.
Learn more
The long term
Manage your dependent patients with long-term maintenance treatment programs.
Learn more
Additional resources
Access helpful videos about managing opioid dependence.
Learn more
World leaders in treating opioid addiction.
Learn more

References: 1. Volkow ND, et al. N Engl J Med 2016;374:363–71. 2. Koob GF & Volkow ND. Neuropsychopharmacology 2010;35:217–38. 3. Gowing L, et al. National Guidelines for Medication-Assisted Treatment of Opioid Dependence. National Expert Advisory Committee on Illicit Drugs (NEACID), Australian Government Department of Health and Ageing. 2014. 4. Lintzeris N, Medicine Today 2015;16(6 Suppl):10–15. 5. Carmichael AN, 2016;7:71–9. 6. Minozzi S, et al. Addiction 2013;108(4):688–98. 7. Suboxone® Film Approved Product Information.